101 related articles for article (PubMed ID: 15213736)
1. Genotoxicity of cis-PtII complex of 3-aminoflavone in comparison with cis-DDP in A549 cells evaluated by comet assay.
Kosmider B; Zyner E; Osiecka R; Ochocki J
Can J Physiol Pharmacol; 2004 May; 82(5):353-8. PubMed ID: 15213736
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of P53 and BAX gene expression and induction of apoptosis and necrosis by the cis-Pt(II) complex of 3-aminoflavone in comparison with cis-diamminedichloroplatinum(II) (cis-DDP) in human lymphocytes.
Kosmider B; Zawlik I; Liberski PP; Osiecka R; Zyner E; Ochocki J; Bartkowiak J
Mutat Res; 2006 Apr; 604(1-2):28-35. PubMed ID: 16443387
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis and necrosis in lymphocytes by the cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP.
Kosmider B; Osiecka R; Ciesielska E; Szmigiero L; Zyner E; Ochocki J
Mutat Res; 2004 Mar; 558(1-2):169-79. PubMed ID: 15036130
[TBL] [Abstract][Full Text] [Related]
4. Comparison between the genotoxicity of cis-Pt(ll) complex of 3-aminoflavone and cis-DDP in lymphocytes evaluated by the comet assay.
Kosmider B; Osiecka R; Zyner E; Ochocki J
Drug Chem Toxicol; 2005; 28(2):231-44. PubMed ID: 15865263
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the genotoxicity of cis-bis(3-aminoflavone)dichloroplatinum(II) in comparison with cis-DDP.
Kosmider B; Wyszynska K; Janik-Spiechowicz E; Osiecka R; Zyner E; Ochocki J; Ciesielska E; Wasowicz W
Mutat Res; 2004 Mar; 558(1-2):93-110. PubMed ID: 15036123
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship and apoptosis induction in A549 cells by the potential anticancer compound cis-bis(3-aminoflavone)dichloroplatinum(II).
Kosmider B; Anuels SA; Evenberg D; Zyner E; Bahmed K; Osiecka R; Ochocki J
Arzneimittelforschung; 2010; 60(3):149-56. PubMed ID: 20422947
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis and necrosis in A549 cells by the cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP.
Kosmider B; Zyner E; Osiecka R; Ochocki J
Mutat Res; 2004 Sep; 563(1):61-70. PubMed ID: 15324749
[TBL] [Abstract][Full Text] [Related]
8. Genotoxicity of novel trans-platinum(II) complex with diethyl (pyridin-4-ylmethyl)phosphate in human non-small cell lung cancer cells A549.
Matlawska-Wasowska K; Rainczuk K; Kalinowska-Lis U; Osiecka R; Ochocki J
Chem Biol Interact; 2007 Jun; 168(2):135-42. PubMed ID: 17499650
[TBL] [Abstract][Full Text] [Related]
9. Enhanced P53 and BAX gene expression and apoptosis in A549 cells by cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP.
Kosmider B; Wojcik I; Osiecka R; Bartkowiak J; Zyner E; Ochocki J; Liberski P
Invest New Drugs; 2005 Aug; 23(4):287-97. PubMed ID: 16012788
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
11. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D
Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of pre-mRNA splicing by cisplatin and platinum analogs.
Schmittgen TD; Ju JF; Danenberg KD; Danenberg PV
Int J Oncol; 2003 Sep; 23(3):785-9. PubMed ID: 12888918
[TBL] [Abstract][Full Text] [Related]
13. Performance of the comet assay in a high-throughput version.
Stang A; Witte I
Mutat Res; 2009 Apr; 675(1-2):5-10. PubMed ID: 19386240
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-induced apoptosis in cultures of human Schwann cells.
Jirsova K; Mandys V; Gispen WH; Bär PR
Neurosci Lett; 2006 Jan; 392(1-2):22-6. PubMed ID: 16236448
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cisplatin-DNA crosslinks formation with UV-C application by the alkaline Comet-assay.
Hovhannisyan GG; Haroutunyan TS; Arutyunyan RM
Exp Oncol; 2004 Sep; 26(3):240-2. PubMed ID: 15494695
[TBL] [Abstract][Full Text] [Related]
16. Nephrotoxic potential of cis-diamminedichloroplatinum and four analogs in male Fischer 344 rats.
Levine BS; Henry MC; Port CD; Richter WR; Urbanek MA
J Natl Cancer Inst; 1981 Jul; 67(1):201-6. PubMed ID: 6942191
[TBL] [Abstract][Full Text] [Related]
17. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].
Hu S; Hu CP; Liang CH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030
[TBL] [Abstract][Full Text] [Related]
18. Toxic variability and radiation sensitization by dichlorodiammineplatinum(II) complexes in Salmonella typhimurium cells.
Richmond RC
Radiat Res; 1984 Sep; 99(3):596-608. PubMed ID: 6382408
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of cis-DDP and pyridoxal effect on isolated DNA during simultaneous application.
Rauko P; Novotný L; Balázová E
Neoplasma; 1993; 40(5):283-8. PubMed ID: 8272156
[TBL] [Abstract][Full Text] [Related]
20. Spin-label substitutions in cisplatin reduce toxicity and interaction with radiation.
Claycamp HG; Shaw EI; Zimbrick JD
Radiat Res; 1986 May; 106(2):141-6. PubMed ID: 3010367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
